Reference
Huang JR, et al. Successful rechallenge of alectinib after remission of severe alectinib-induced interstitial lung disease. Journal of Oncology Pharmacy Practice 27: 1311-1314, No. 5, Jul 2021. Available from: URL: http://doi.org/10.1177/1078155220961557
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1866, 22 (2021). https://doi.org/10.1007/s40278-021-99718-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-99718-9